Understanding DNA starting material for mRNA production

Charlotte Barker, Commissioning Editor, Vaccine Insights, speaks to Lawrence Thompson, Associate Research Fellow, Pfizer, about advances and challenges in DNA starting materials for mRNA vaccine production, including gaps in guidance, the growing role of synthetic DNA starting material, and the transition of next-generation sequencing techniques into GMP environments.

Please enter your email to access content Read now